Cas13a/C2c2 - A Dual Function Programmable RNA Endoribonuclease

Tech ID: 25839 / UC Case 2016-163-0

Patent Status

Country Type Number Dated Case
United States Of America Issued Patent 10,494,664 12/03/2019 2016-163
United States Of America Issued Patent 10,337,051 07/02/2019 2016-163
United Kingdom Issued Patent 2557153 03/20/2019 2016-163
European Patent Office Published Application 3471749 04/24/2019 2016-163
China Published Application CN109641026A 04/16/2019 2016-163
Germany Published Application 21 2017 000 061 01/10/2019 2016-163
Germany Published Application 21 2017 000 062 01/10/2019 2016-163
Germany Published Application 212017000056 12/12/2018 2016-163
United States Of America Published Application 20180208976 07/26/2018 2016-163
Australia Published Application WO 2017/218573 12/21/2017 2016-163
Canada Published Application WO 2017/218573 12/21/2017 2016-163
Japan Published Application WO 2017/218573 12/21/2017 2016-163
Patent Cooperation Treaty Published Application WO2017218573 12/21/2017 2016-163
 

Additional Patents Pending

Brief Description


Bacterial adaptive immune systems employ CRISPRs and CRISPR-associated (Cas) proteins for RNA-guided nucleic acid cleavage. Although generally targeted to DNA substrates, the Type VI CRISPR system directs interference complexes against single-stranded RNA substrates and in Type VI CRISPR systems, the single-subunit Cas13a/C2c2 protein functions as an RNA-guided RNA endonuclease.

 

UC Berkeley researchers have discovered that the CRISPR-Cas13a/C2c2 has two distinct RNase activities that enable both single stranded target RNA detection and multiplexed guide-RNA processing.  These dual RNase functions were found to be chemically and mechanistically different from each other and from the CRISPR RNA processing behavior of the evolutionarily unrelated CRISPR enzyme Cpf1.  Methods for detecting the single stranded target RNA were also discovered using a Cas13a/C2c2 guide RNA and a Cas13a/C2c2 protein in a sample have a plurality of RNAs as well as methods of cleaving a precursor Cas13a/C2c2 guide RNA into two or more Cas13a/C2c2 guide RNAs.

 

Suggested uses


 

  • Multiplexed guide-RNA processing
  • Diagnostic for sensitive target RNA detection

 

Advantages

 

  • Detects target RNA directly without considerable engineering or stringent design constraints for each new RNA target
  • Cleavage potent and detectable at extremely low levels of activated protein
  • Highly specific method of detection
  • Conventional detection methods can be used (e.g., using a labeled detector RNA)

 

Publication

Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection

Learn About UC TechAlerts - Save Searches and receive new technology matches

Inventors

  • Doudna, Jennifer A.

Other Information

Keywords

Cas13a,CRISPR, genome editing, RNA, C2c2

Categorized As